Remdesivir had been the first medication to be approved by the U.S. FDA for Emergency Use Authorization (EUA) for the treatment of adult and pediatric patients with suspected or laboratory-confirmed SARS-CoV-2 infection and severe COVID-19. Also, it became the first medicine against COVID-19 to be recommended for authorization in the EU by the EMA.

(Favipiravir 200 mg) The Japanese antiviral Avigan, which is used to treat severe influenza, respiratory viruses, and mild to moderate COVID-19 patients.

(Hydroxychloroquine sulfate 200 mg) is an antiviral product for the treatment of uncomplicated malaria. Also, it can be prescribed for the treatment of mild and moderate COVID-19 cases as per Egyptian protocol for COVID-19 management.
Dose: 400 mg “two tablets” twice on the first day then 200 mg “one tablet” twice for 6 days.